CN HEALTH TONGRENTANG2020-11-11
China Beijing Tongrentang (Group) Co., Ltd. is a wholly state-owned company authorized by the municipal government to operate state-owned assets. Tongrentang was founded in 1669 and has a history of more than 300 years. Beijing Tongrentang has always adhered to the development strategy of “taking modern Chinese medicine as the core, developing the life and health industry, and becoming an internationally renowned modern Chinese medicine group”, with the policy of “growth, stronger, and bigger”, and lead the enterprise with innovation and technology As its own responsibility, it has formed three major sectors of modern pharmaceutical industry, retail business and medical services, and built a corporate structure of six secondary groups, three hospitals and two reserve units. Currently, it has three listed companies. The group has a total of more than 1,500 products such as medicines, hospital preparations, health foods, foods, and cosmetics, 28 production bases, 83 modern production lines, a national engineering center and post-doctoral research workstations.
Since 1997, Tongrentang has maintained sustained and healthy development, and its economic indicators have maintained double-digit growth for 15 consecutive years, doubling every five years. As of 2011, the group’s total assets were 14 billion yuan, sales revenue was 16.3 billion yuan, profits were 1.316 billion yuan, foreign exchange earnings were 33.92 million U.S. dollars, and 64 pharmacies and 1 overseas production and R&D base were opened in 16 overseas countries and regions. Sold to more than 40 countries and regions overseas.
With the rapid development of Tongrentang, fruitful results have been achieved in brand maintenance and promotion, and cultural innovation and inheritance. “Tongrentang Traditional Chinese Medicine Culture” has been included in the first batch of national intangible cultural heritage lists. Tongrentang is both an economic entity and a culture. The dual function of the carrier is increasingly emerging.